Cell line · CVCL_0515
SaOS-LM7
Cancer cell line, Homo sapiens. Osteosarcoma. 13 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SaOS-LM7. Cell lines, record CVCL_0515. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0515
On this page
Cell line
As Cellosaurus gives it.
- Name
- SaOS-LM7
- Accession
- CVCL_0515
- RRID
- RRID:CVCL_0515
- Synonyms
- SAOS-LM7, Saos-LM7, SaOs-lm7, SaOS/LM7, LM7
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 11Y
- Category
- Cancer cell line
- Diseases
- Osteosarcoma (NCIt C9145); Osteosarcoma (ORDO Orphanet_668)
- Derived from
- Bone (in situ)
- Parent
- SaOS-LM6 (CVCL_9568)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers13
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Drug Screening of Sarcoma Cells: Finding Shared Sensitivities. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LRRC15-CAR T Cells for the Treatment of Osteosarcoma. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas. | Cancer Immunol Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis. | Cancer Lett | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition. | Front Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma. | Int J Cancer | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. | Nat Med | 2018 | Cellosaurus cites it | PubMed | |
| Characterization of the metastatic phenotype of a panel of established osteosarcoma cells. | Oncotarget | 2015 | Cellosaurus cites it | PubMed |
1 to 10 of 13
See all 13 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | SaOS-LM6 | CVCL_9568 |
Source Cell lines
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0515
GET https://conductscience.org/api/cell-lines/v1/CVCL_0515/problems